Passage Bio
Dave Bottari is currently the Head of Quality Assurance - Executive Director at Passage Bio. Prior to that, Dave held various Quality Assurance roles at Spark Therapeutics, Inc. and Endo Pharmaceuticals (formally Auxilium Pharmaceuticals). Dave also started their career as a Quality Assurance Technician in packaging at Auxilium Pharmaceuticals, Inc. Dave obtained their Bachelor of Arts degree from Cabrini University in 2018.
Passage Bio
1 followers
Passage Bio is a genetic medicines company based in Philadelphia, PA that is developing a deep pipeline of adeno-associated virus (AAV) delivered therapeutics for the treatment of rare monogenic central nervous system disorders (CNS).